These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28358620)

  • 1. Daily Coffee Intake Inhibits Pancreatic Beta Cell Damage and Nonalcoholic Steatohepatitis in a Mouse Model of Spontaneous Metabolic Syndrome, Tsumura-Suzuki Obese Diabetic Mice.
    Watanabe S; Takahashi T; Ogawa H; Uehara H; Tsunematsu T; Baba H; Morimoto Y; Tsuneyama K
    Metab Syndr Relat Disord; 2017 May; 15(4):170-177. PubMed ID: 28358620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous onset of nonalcoholic steatohepatitis and hepatocellular carcinoma in a mouse model of metabolic syndrome.
    Nishida T; Tsuneyama K; Fujimoto M; Nomoto K; Hayashi S; Miwa S; Nakajima T; Nakanishi Y; Sasaki Y; Suzuki W; Iizuka S; Nagata M; Shimada T; Aburada M; Shimada Y; Imura J
    Lab Invest; 2013 Feb; 93(2):230-41. PubMed ID: 23212097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verification of the Impact of Blood Glucose Level on Liver Carcinogenesis and the Efficacy of a Dietary Intervention in a Spontaneous Metabolic Syndrome Model.
    Ichimura-Shimizu M; Kageyama T; Oya T; Ogawa H; Matsumoto M; Sumida S; Kakimoto T; Miyakami Y; Nagatomo R; Inoue K; Cheng C; Tsuneyama K
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of coffee or coffee components on gut microbiome and short-chain fatty acids in a mouse model of metabolic syndrome.
    Nishitsuji K; Watanabe S; Xiao J; Nagatomo R; Ogawa H; Tsunematsu T; Umemoto H; Morimoto Y; Akatsu H; Inoue K; Tsuneyama K
    Sci Rep; 2018 Nov; 8(1):16173. PubMed ID: 30385796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of 8-hydroxydeoxyguanosine, L-arginine and Glucose Metabolites by Liver Tumor Cells Are the Important Characteristic Features of Metabolic Syndrome and Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis.
    Kakehashi A; Suzuki S; Ishii N; Okuno T; Kuwae Y; Fujioka M; Gi M; Stefanov V; Wanibuchi H
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models for analyzing metabolic syndrome-associated liver diseases.
    Tsuneyama K; Nishitsuji K; Matsumoto M; Kobayashi T; Morimoto Y; Tsunematsu T; Ogawa H
    Pathol Int; 2017 Nov; 67(11):539-546. PubMed ID: 29027308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous Occurrence of Various Types of Hepatocellular Adenoma in the Livers of Metabolic Syndrome-Associated Steatohepatitis Model TSOD Mice.
    Shao W; Jargalsaikhan O; Ichimura-Shimizu M; Cai Q; Ogawa H; Miyakami Y; Atsumi K; Tomita M; Sutoh M; Toyohara S; Hokao R; Kudo Y; Oya T; Tsuneyama K
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of splenic iron accumulation in the development of nonalcoholic steatohepatitis in Tsumura Suzuki Obese Diabetes mice.
    Murotomi K; Arai S; Uchida S; Endo S; Mitsuzumi H; Tabei Y; Yoshida Y; Nakajima Y
    Sci Rep; 2016 Mar; 6():22476. PubMed ID: 26932748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis-associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects.
    Kawakubo M; Tanaka M; Ochi K; Watanabe A; Saka-Tanaka M; Kanamori Y; Yoshioka N; Yamashita S; Goto M; Itoh M; Shirakawa I; Kanai S; Suzuki H; Sawada M; Ito A; Ishigami M; Fujishiro M; Arima H; Ogawa Y; Suganami T
    Sci Rep; 2020 Jan; 10(1):983. PubMed ID: 31969650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a novel mouse model of diet-induced nonalcoholic steatohepatitis-related progressive bridging fibrosis.
    Ichimura-Shimizu M; Omagari K; Yamashita M; Tsuneyama K
    Biosci Biotechnol Biochem; 2021 Mar; 85(4):941-947. PubMed ID: 33620426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tsumura-Suzuki obese diabetic mice-derived hepatic tumors closely resemble human hepatocellular carcinomas in metabolism-related genes expression and bile acid accumulation.
    Takahashi T; Deuschle U; Taira S; Nishida T; Fujimoto M; Hijikata T; Tsuneyama K
    Hepatol Int; 2018 May; 12(3):254-261. PubMed ID: 29651702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic steatohepatitis in morbid obese patients: coffee consumption vs. disease severity.
    Barros RK; Cotrim HP; Daltro C; Alves E; de Freitas LA; Daltro C; Oliveira Y
    Ann Hepatol; 2016; 15(3):350-5. PubMed ID: 27049488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies.
    Marventano S; Salomone F; Godos J; Pluchinotta F; Del Rio D; Mistretta A; Grosso G
    Clin Nutr; 2016 Dec; 35(6):1269-1281. PubMed ID: 27060021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and low sympathetic nerve activity in the Tsumura Suzuki obese diabetic mouse: a new model of spontaneous type 2 diabetes mellitus and obesity.
    Takahashi A; Tabuchi M; Suzuki W; Iizuka S; Nagata M; Ikeya Y; Takeda S; Shimada T; Aburada M
    Metabolism; 2006 Dec; 55(12):1664-9. PubMed ID: 17142141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of cardiovascular function in Tsumura Suzuki obese diabetes, a new model mouse of type 2 diabetes.
    Kawada T; Miyata S; Shimada T; Sanzen Y; Ito M; Hemmi C; Iizuka S; Suzuki W; Mihara K; Aburada M; Nakazawa M
    Biol Pharm Bull; 2010; 33(6):998-1003. PubMed ID: 20522966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium alginate prevents progression of non-alcoholic steatohepatitis and liver carcinogenesis in obese and diabetic mice.
    Miyazaki T; Shirakami Y; Kubota M; Ideta T; Kochi T; Sakai H; Tanaka T; Moriwaki H; Shimizu M
    Oncotarget; 2016 Mar; 7(9):10448-58. PubMed ID: 26871288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Liver disorders in diabetic patients].
    Brůha R; Dvořák K; Petrtýl J
    Vnitr Lek; 2013 Jul; 59(7):546-50. PubMed ID: 23909257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of bone strength and metabolism in type 2 diabetic model Tsumura, Suzuki, Obese Diabetes mice.
    Tanaka H; Yamashita T; Yoneda M; Takagi S; Miura T
    Bone Rep; 2018 Dec; 9():74-83. PubMed ID: 30094297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism Analysis and Prevention of Pathogenesis of Nonalcoholic Steatohepatitis].
    Nakajima T; Naito H
    Nihon Eiseigaku Zasshi; 2015; 70(3):197-204. PubMed ID: 26411937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis.
    Albhaisi S; Sanyal AJ
    Front Endocrinol (Lausanne); 2021; 12():665987. PubMed ID: 34040583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.